11.6.4 Carbonic anhydrase inhibitors and systemic drugs

1st line choice

Usual administration: three times a day (mono therapy)
Twice a day (dual therapy with topical beta-blocker)

Excipients depend on manufacturer

Contain benzalkonium chloride

5 ml
5 ml

2nd choice to be considered where there is intolerance to dorzolamide or it has not been effective.

Administration twice a day

Contain benzalkonium chloride, disodium edetate

5 ml
  • First Line Drugs
  • Second Line Drugs
  • Specialist Initiated Drugs
  • Specialist Only Drugs
  • Mixed Status